Background {#Sec1}
==========

Perineuriomas (PN) are rare benign peripheral nerve sheath tumours originating from perineurial cells. Intraneural and extraneural PN have to be distinguished. The intraneural PN is restricted to the boundaries of the peripheral nerve, whereas the extraneural PN is found mainly in soft tissues and skin \[[@CR1]\].

They arise from perineural cells located in the perineurium of the peripheral nerve, which is histologically characterized by a complex perineurial cell proliferation, which extends into the endoneurium and surrounds concentrically individual myelinated and the unmyelinated axon-Schwann cell complexes of peripheral nerve fascicles and endoneurial capillaries. This leads to the characteristic "pseudo-onion bulbs" \[[@CR2]\]. It is known that the perineurium forms the blood-nerve barrier and has continuity with the pia-arachnoid membrane of the central nervous system \[[@CR3], [@CR4]\]. A neoplastic origin for intraneural and soft tissue PN is suggested due to the presence of 22q deletions \[[@CR5], [@CR6]\]. However, recently performed genomic analysis indicates divergent pathogenetic mechanisms of intraneural PN and soft tissue PN. The intraneural PN frequently contains TRAF7 mutations \[[@CR7]\], and rarely, chr22q12 deletions whereas the soft tissue PN showed no TRAF7 mutations. Alterations in NF1 or NF2 likely contribute to perineurioma pathogenesis, similar to other nerve sheath tumours \[[@CR8]\].

They most commonly present a mononeuropathy of gradual onset and slow progression, resulting in progressive neurological deficits like hypoesthesia or motor weakness \[[@CR9], [@CR10]\]. It is believed that the motoric fascicles are affected by the tumour, there as the sensory deficits are caused by the intraneural compression of the sensoric fascicles.

Those lesions can be difficult to diagnose due to their rarity. Up to now, guidelines do not exist, and the management of this rare pathology is still various.

Therefore, we retrospectively analysed our dataset "peripheral nerve lesion" to identify patients suffering from perineuriomas. Aim of the study was to compare our surgical treatment and our follow-up regime including high-resolution nerve sonography (HRNS) with the current literature.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

Retrospective analysis of our dataset "peripheral nerve lesion" was performed between 01.01.2012 until 31.12.2018. Three patients suffering from an intraneural PN were identified. Patients were treated in our department using following surgical technique: microsurgical interfascicular neurolysis in combination with a biopsy of a non-functional fascicle. Medical records, pre- and postoperative HRNS and MRI were analysed. Follow-up examination and postoperative HRNS were evaluated up to 2½ years after surgery.

The study was approved by the Institutional Review Board (Medical Faculty, University of Duisburg-Essen, Registration number: 18--7955-BO).

Surgery {#Sec4}
-------

Preoperative HRNS was used to identify the affected nerve and to plan the extend of the skin incision followed by sterile washing and draping of the surgical field. After skin incision, careful preparation towards the nerve was performed. The affected nerve can be identified by its pathologically changed surface structure with an enlarged epineurium that covers the thickened fascicles. Intraoperative HRNS was now used to visualise the affected nerve and to plan the extend of the epineural opening. Microsurgical interfascicular neurolysis can be achieved after careful longitudinal incision of the epineurium. Electrophysiological stimulation (0.1--0.2 mA) of each fascicle shows the ones with motor function. An enlarged fascicle without motor function is identified for a targeted fascicular biopsy (4 mm length). If possible, end-to-end anastomosis should be performed afterwards to prevent microneuroma.

Systematic review of the literature {#Sec5}
-----------------------------------

A systematic search via PubMed, the Cochrane Collaboration Library, Scopus and Google Scholar was performed for literature published between January 1, 1990 and October 31, 2019 independently by 2 authors.

Search key words comprised "intraneural perineurioma", "intraneural perineuriomas" and "localized hypertrophic mononeuropathy". Inclusion criteria were articles published in English presenting the clinical course, peripheral nerve location, and the treatment regime. Therefore, cases without description of the surgical treatment were excluded.

Afterwards, the reference lists of included articles were reviewed to identify and include additional eligible articles. Furthermore, all included studies were meticulously cross-referenced to ensure that patients were not included in multiple articles (Fig. [1](#Fig1){ref-type="fig"}). The systematic review was conducted following *Preferred Reporting Items for Systematic Reviews and Meta-Analyses* guidelines \[[@CR11]\]. Fig. 1PRISMA flow chart demonstrating the systematic review of the literature

Statistical analysis {#Sec6}
--------------------

Data were analysed using SPSS 23.0 (Statistical Package for the Social Sciences, SPSS Inc., Chicago, IL, USA). Metric data were described by mean and standard deviation and nominal data by frequency and valid percent.

Results {#Sec7}
=======

Case presentations {#Sec8}
------------------

### Case 1 {#Sec9}

A 56-year-old male patient with typical clinical and electroneurographic findings of carpal-tunnel-syndrome caused by an intraneural PN of the right median nerve presented to our neurosurgical department. The patient complaint about a progressive hypaesthesia and paresis of the hand and underwent 4 surgeries over a period of 30 years without long term benefit because of suspected carpal-tunnel-syndrome. HRNS and magnetic resonance imaging (MRI) of the right-hand depicted an intraneural PN of the median nerve (Fig. [2](#Fig2){ref-type="fig"}). Follow-up examination 27 months after surgery showed an improvement in motor function undergoing physiotherapy, but no change of the sensory deficits. HRNS revealed stable intraneural PN. Fig. 2HRNS (**c** + **f**) and MRI (**a** + **d**) of the right-hand depicted nerve enlargement (asterisk) with perineurial tissue and still identifiable fascicular structure. Intraoperative view showing the perineurioma (**b** + **e**)

### Case 2 {#Sec10}

A 16-year-old left-handed male patient presented with an intraneural PN of the left ulnar nerve. Symptoms lasted over 2 years, showing a progressive atrophy of the intrinsic muscles of the left hand without any sensory deficit. Electrophysiological testing revealed an impairment of the left ulnar nerve, HRNS and MRI of the left arm showed intraneural PN of the ulnar nerve with a length of about 15 cm reaching from the middle of the upper arm to the middle of the forearm (Fig. [3](#Fig3){ref-type="fig"}). Despite the atrophy of the intrinsic muscles of the hand, follow-up examination 24 months after surgery showed a stable state of the PN on HRNS, without any sensory deficit. The functionality of the hand improved under consequent physiotherapy. Fig. 3HRNS (**b** + **c**) and MRI (**a** + **d**) of the left forearm depicted nerve enlargement (asterisk) with perineurial tissue and still identifiable fascicular structure. Intraoperative view showing the perineurioma (**e**)

### Case 3 {#Sec11}

A 17-year-old female patient complained about progressive impairment of foot elevation over a period of 3 years, showing a paresis of 2/5. The patient was treated by the neurologist due to the suspicious of an idiopathic peroneal paresis. Electrophysiological testing showed impairment of the left peroneal nerve. HRNS and MRI of the left leg revealed an intraneural PN of peroneal nerve (Fig. [4](#Fig4){ref-type="fig"}). Postoperative, the paresis of the foot elevation increased to 1/5. Follow-up examination 30 months after surgery showed an improvement of the foot elevation, now 3/5. Fig. 4HRNS (**c** + **f**) and MRI (**a** + **d**) of the left upper limb depicted nerve enlargement (asterisk) with perineurial tissue and still identifiable fascicular structure. Intraoperative view showing the perineurioma (**b** + **e**)

Histopathology {#Sec12}
--------------

Histology of the biopsy specimen showed intrafascicular tumour cells surrounded by collagen fibres. Epithelial membrane antigen staining highlights concentric layers of tumour cells. S100 is not expressed in tumour cells but positive in the pre-existent Schwann cells. Immunohistochemical staining for Ki-67 reveals only very few proliferating tumour cells (Fig. [5](#Fig5){ref-type="fig"}). All cases showed a similar histomorphology and a comparable immunohistochemical expression profile, so that an intraneural PN was diagnosed in all cases. Fig. 5Histology of the biopsy specimen (Hematoxylin and eosin stain) with intrafascicular tumour cells (asterisk) surrounded by collagen fibres (**a**). Epithelial membrane antigen staining is positive in tumour cells (asterisk) (**b**). S100 is not expressed in tumour cells but shows entrapped Schwann-cells in pseudo-onion bulbs (asterisk) (**c**). Immunohistochemical staining for Ki-67 reveals only very few proliferating tumour cells (asterisk) (**d**)

Results of the systematic review {#Sec13}
--------------------------------

The search resulted in 914 articles, after analysing the title and abstract 857 articles were excluded. The full text of the remaining 57 articles was reviewed and 35 articles were then excluded. Therefore, 22 articles met the inclusion criteria \[[@CR5], [@CR9], [@CR12]--[@CR31]\], comprising 74 cases of PN (Table [1](#Tab1){ref-type="table"}). Table 1Results of the systematic review of the literature, including cases in which surgical treatment and follow-up is includedYearReferenceAge (Years)SexNerve involvedTherapyFollow-upOutcome1991Phillips et al. \[[@CR12]\]Nmmaleulnarneurolysis complete resection + nerve graft6 monthsparalysis1995Emory et al. \[[@CR5]\]12malesciaticfascicular biopsy48 monthsunchanged35femaleulnarfascicular biopsy36 monthsunchanged31malesciatic-tibial-branchfascicular biopsy17 monthsunchanged15malemedianfascicular biopsy12 monthsunchanged38femaleposterior interosseuscomplete resection + nerve graft3 monthsworse18femalefemoralcomplete resection + nerve graft6 monthsworse11femaleC8 & T1 nerve rootfascicular biopsy1 monthsunchanged13femaleperonealfascicular biopsy3 monthsunchanged1998Gruen et al. \[[@CR13]\]4femalemediancomplete resection + nerve graft5 yearsimproved14femaleperonealcomplete resection + nerve graft2 yearslittle change8maleperonealcomplete resection + nerve graft2.5 yearsfoot brace4malemediancomplete resection + nerve graft5 yearsfair sensation, good thenar intrinsic motor function12malesciaticinternal neurolysis4 yearsExcellent pushdown, plantar sensation, foot brace38femalemedianinternal neurolysis6 yearsreduced function21femalebrachial plexuscomplete resection + nerve graft6 yearsunchanged16femaleperonealcomplete resection + nerve graft4.25 yearsimproved37maleulnarinternal neurolysis4 yearspartial recovered37maleradialinternal neurolysis0,5 yearsno follow-up16malemediancomplete resection + nerve graft3 yearsgood recovery to date38femaleradialcomplete resection + nerve graft2 yearsGood recovery to date8femaleperonealcomplete resection + nerve graft0.5 yearsnone recovery43femaleperonealcomplete resection + nerve graft1 yearearly recovery1999Simmons et al. \[[@CR14]\]17femalefemoralcomplete resection + nerve graft10 monthsunchanged12femalesciaticcomplete resection + nerve graft2.5 yearsunchanged26femalebrachial plexuscomplete resection + nerve graft2 monthsunchanged19maleBrachial plexusneurolysis6 monthsimprovement2000Jazayeri et al. \[[@CR15]\]53maleMmdiancomplete resection + nerve graft11 monthsunchanged2001Alfonso et al. \[[@CR16]\]2femalemediancomplete resection + nerve graft12 monthsunchangedHeilbrun et al. \[[@CR17]\]28femaleperonealdissection5 yearsunchanged2004Beekman et al. \[[@CR18]\]36femaleulnarneurolysis6 monthsimprovedIsaac et al. \[[@CR19]\]2femaleradialComplete resection + nerve graft3 yearsunchanged2005Cortes et al. \[[@CR20]\]9femaleradialcomplete resection + nerve graft6 monthsmild improvement2007Boyanton et al. \[[@CR21]\]5maleulnarcomplete resection + nerve graft3 yearssome motor improvementNguyen et al. \[[@CR22]\]30femaleradialneurolysis, biopsy and tendon transfer10 monthsimproved2008Gürkan et al. \[[@CR23]\]42femalemedianbiopsy16 monthsimprovedScheller et al. \[[@CR24]\]5maleradialcomplete resection + nerve graftPostoperative Periodunchanged10maleperonealcomplete resection + nerve graft5 monthsunchanged20maleradialcomplete resection + nerve graftpostoperativefirst reinnervation29maleulnarcomplete resection + nerve graftpostoperativemild improvement2009Mauermann et al. \[[@CR9]\]12femalesciaticbiopsy5 monthsunchanged7malrsciaticbiopsy6 monthsunchanged2femalelumbosacral plexusbiopsy18 monthsImprovement in sensation12femalesciaticbiopsy78 monthsunchanged35maletibialbiopsy6 monthsunchanged31maletibialbiopsy177 monthsimprovement in stabbing sensation15femalelumbosacral plexusbiopsy88 monthsmild increased weakness56maleradialbiopsy53 monthsmild increased weakness19femalefemoralbiopsy168 monthsincreased weakness7femalesciaticbiopsy118 monthsunchanged34malesciaticbiopsy45 monthsincreased numbness12femalebrachial plexusbiopsy37 monthsincreased weakness35malebrachial plexusbiopsy36 monthsworsened temperature discrimination30femaleradialbiopsy27 monthsimproved in weakness and numbness14malesciaticbiopsy24 monthsincreased atrophy30malesciaticbiopsy18 monthsunchanged12malebrachial plexusbiopsy34 monthsincreased atrophy8malesciaticbiopsy135 monthsimprovement in weakness19femaleulnarbiopsy127 monthsunchanged8malesciaticbiopsy14 monthsunchanged13femaleulnarbiopsy8 monthsmild increased weakness37maletibialbiopsy6 monthsunchangedSachanandani et al. \[[@CR25]\]23femalemedianfascicular biopsy1 monthsunchanged2010Ferraresi et al. \[[@CR26]\]4maleperonealcomplete resection + nerve graft7 yearsunchanged9malesciaticcomplete resection + nerve graft8 yearsunchanged13femaleperonealneurolysis4 yearsunchanged14femalesciaticneurolysis5 yearsunchanged2011Groeneweg \[[@CR27]\]22maleulnarneurolysis + fascicular biopsynmpartial improvement2012Lavi et al. \[[@CR28]\]18femalebrachial plexusbiopsy + extzernal neurolysis1 weekimproved2014Chung et al. \[[@CR29]\]58Femalebrachial plexusinterfascicular dissection18 monthsnearly normal2016Dahlin et al. \[[@CR30]\]21malesciaticfascicular biopsynmunchangedMcMillan et al. \[[@CR31]\]13femaleradialcomplete resection + nerve graft10 monthsworse14femalefemoralcomplete resection + end-t-side nerve transfer18 monthsmild improvementCase 156malemedianfascicular biopsy + neurolysis interfascicular27 monthsimprovementCase 216maleulnarfascicular biopsy + neurolysis interfascicular24 monthsimprovementCase 317femaleperonealfascicular biopsy + neurolysis interfascicular30 monthsimprovement

Including our three cases, demographics, surgical treatment and the neurological outcome were analysed for 77 patients.

Demographics {#Sec14}
------------

Mean age was 21.0 ± 13.9 years of age, 42 females (54.5%). Mean follow-up was 35.2 months. Sciatic nerve was affected mostly (*n* = 16, 20.8%), followed by peroneal (*n* = 11, 14.3%) and median nerve affection (n = 11, 14.3%).

High-resolution nerve sonography {#Sec15}
--------------------------------

Typically, PN present as a fusiform enlargement of the nerve fascicles over several centimetres with hyperechoic perineurial tissue on HRNS. Fascicular structure of the enlarged nerves remains visible.

Magnetic resonance imaging {#Sec16}
--------------------------

Normally, PN show isointensity on T1-weighted and hyperintensity on T2-weighted MRI. Intraneural PN can show highly increased signal along the nerve on Short-Tau Inversion Recovery sequence with identifiable fascicles. Homogenous, moderate to strong contrast enhancement can be detected on T1-weighted contrast enhanced MRI.

Surgery {#Sec17}
-------

Biopsy was performed in 32 patients (41.6%), complete resection and nerve grafting was performed in 28 cases (36.4%), whereas neurolysis (*n* = 12, 15.6%) or fascicular biopsy and interfascicular neurolysis (*n* = 5, 6.5%) was performed less.

Neurological outcome {#Sec18}
--------------------

Neurological outcome was unchanged in 35 cases (45.5%), worsened in 16 cases (20.8%). Neurological improvement was detected in 26 patients (33.8%).

Analysis of the review of the literature revealed similar results between the different surgical treatment options. Complete resection with nerve grafting showed unchanged neurological outcome in 46.4% and an improvement in 35.7%. Single biopsy showed unchanged results of the neurological outcome in 53.1% and an improvement in18.8%. Unchanged neurological outcome was detected in 41.6% and improved neurological outcome was seen in 41.6% of the cases treated with neurolysis (Table [2](#Tab2){ref-type="table"}). Table 2Different surgical therapy and its neurological outcomeSurgical TreatmentNeurological outcomeWorsenedUnchangedImprovedComplete resection + nerve graft5 (17.9%)13 (46.4%)10 (35.7%)Biopsy9 (28.1%)17 (53.1%)6 (18.8%)Fascicular biopsy + neurolysis005 (100%)Neurolysis2 (16.8%)5 (41.6%)5 (41.6%)

Discussion {#Sec19}
==========

Intraneural PNs are rare benign peripheral nerve sheath tumours originating from perineurial cells, presenting slowly progressive, motor predominant focal neuropathy or plexopathy with mild sensory symptoms and signs \[[@CR9]\].

Probably, intraneural PN is an under-diagnosed focal neuropathy, but more cases were detected over the last years due to a multidisciplinary approach by experts in peripheral nerve care, peripheral nerve imaging including HRNS, peripheral nerve surgery, electrophysiology and peripheral nerve pathology.

On MRI, PNs typically present as a fusiform enlargement of the nerve fascicles, isointense on T1-weighted and moderate to strong hyperintensity on T2-weighted MR images with moderate to strong homogenous contrast enhancement after intravenous gandolinium application \[[@CR9], [@CR32]\]. On HRNS examinations, a nerve enlargement over several centimetres with hyperechoic perineurial tissue can be detected. Fascicular structure of the enlarged nerves is still identifiable \[[@CR10]\]. Up to date, HRNS is more and more commonly used for peripheral neuropathies \[[@CR33]\], and is a well-established diagnostic tool, which can be used for follow-up examinations of known PNs. We believe that tumour growth can be detected easily with HRNS. Therefore, HRNS plays an important role in diagnosis and especially in follow-up examination in combination with the neurological examinations and the findings of the electrophysiological testing.

However, the treatment of intraneural PN is still a subject of great controversy despite several studies, mainly case reports, on this topic. A general consensus still does not exist. Surgery is commonly recommended in patients with a progressive neurological deficit and a localizable single lesion.

Gruen et al. recommended in their series of intraneural PNs that a surgical treatment should include resection of the lesion with interpositional nerve graft repair in cases where intraoperative nerve action potentials demonstrate a non-functioning or poorly functioning segment. Additionally, intraoperative histological examination is recommended to confirm onion- bulb neuropathy. They reported in their series, including 14 patients with localized hypertrophic neuropathy, the postoperative outcome after surgery. Seven out of 10 patients who received nerve grafting showed an improvement of the motor function. Four patients did not receive nerve grafting, but two of those patients recovered some function. Therefore, Gruen et al. concluded that routine nerve grafting should be performed \[[@CR13]\].

Gruen and Kline also recommend that the lesion should be carefully resected until normal appearing fascicles and a bit further both proximally and distally of the lesion and nerve graft should be interposed, if no action potential or if poor amplitude was recorded across the lesion. More extensive nerve resection is made to avoid that the interpositioned nerve graft may eventually deteriorate as well, leading to a longer graft and therefore to poorer results \[[@CR34]\]. In our opinion, extensive nerve resection and following nerve grafting has to be considered in patients with more distal located focal lesion without muscle atrophy. Otherwise, there is always the possibility of worsening disability or pain after surgical treatment of the nerve. Those criteria meet only in a few cases so that nerve resection should usually not be performed.

Heilbrun et al. reviewed the treatment options in patients with intraneural PN. They found 16 patients treated with resection of the tumour and nerve grafting. Collected follow-up information showed an improvement of motor function in eight cases and a slight improvement in two more patients. Three of five patients treated by tumour excision alone also demonstrated an improvement of the neurological deficits. They concluded that nerve grafting should be based on individually indications including negative intraoperative action potentials \[[@CR17]\]. Early identification of the lesion and the treatment opportunity prior to irreversible deterioration of distal intramuscular nerve sheaths and longstanding denervation atrophy are also an important factor influencing the neurological outcome. Functional recovery after nerve grafting is most favourable in young patients \[[@CR20]\].

Sachanandani et al. recommended as an alternative to proximal nerve grafting a distal nerve transfer in patients with progressive neuropathies due to several reasons. Widely resection of the lesion is possible using a nerve reconstruction that is distant to the lesion without any concern for the length of graft required \[[@CR25]\]. Furthermore, reinnervation of the target musculature might be more successful to decreased length of regeneration required, elimination of an additional repair site, and exclusion of grafts \[[@CR35]\]. Additionally, harvesting a nerve graft using a second surgery site and possible causing further deficits may be avoided \[[@CR25]\].

Mauermann et al. present a dissenting opinion of the treatment of intraneural PN. In their opinion and current clinical practice, targeted fascicular nerve biopsy at the site of MRI lesion has to be performed as a much more focused nerve biopsy minimizing surgical deficits and postoperative scarring. Other surgical interventions such as tendon transfers or distal nerve grafting may be performed as a second stage procedure in patients there a static disease is evident after receiving the definitive diagnosis. Furthermore, clinically follow-up with imaging to verify clinical stability may be reasonable in patients there the nerve lesion is difficult to access without major invasive surgery \[[@CR9]\].

We are in line with the therapeutically approach performing a targeted fascicular nerve biopsy at the site of MRI or HRNS lesion, but in our cases additionally interfascicular neurolysis, which is known to be a safe and reliable technique \[[@CR36]\] had a positive impact on the neurological outcome.

Contrary to the common view and contrary to our approach, Restrepo et al. believe that a targeted fascicular biopsy is not necessary in patients there the clinical presentation (slowly progressive painless neuropathy and motor dysfunction with atrophy in the affected nerve territory) and the radiological imaging are typical for the presence of intraneural PN \[[@CR37]\]. In our opinion, a targeted biopsy under electrophysiological monitoring is mandatory to receive a definitive diagnosis even in cases there the clinical presentation and the radiological imaging is highly suspicious of an intraneural PN to avoid unnecessary treatment.

However, neurological outcome did not differ between the analysed surgical treatment options (Table [2](#Tab2){ref-type="table"}). Radiological evaluations of PN revealed more information about the course of this rare tumour. This might shift the surgical treatment from total resection and nerve grafting towards less invasive methods like targeted fascicular biopsy for diagnostic and wait-and-see strategies. This was suggested by Wilson et al., who were able to show that intraneural PN rarely growth in length and that they do not grow to involve new nerves or nerve divisions. Furthermore, growth does not correlate with clinical progression. Therefore, they concluded that intraneural PN have special characteristics, which can be detected radiological and which would make invasive diagnostic unnecessary \[[@CR38]\].

Several limitations have to be addressed. First, this is a systematic review about a rare tumour. Therefore, we were only able to review case reports and small case studies. The informative value of those low evidence articles must be kept in mind. Secondly, neurological outcome was described only for several months.

However, future prospective studies with a longer follow-up are needed to evaluate the neurological long-term outcome in those patients.

Conclusion {#Sec20}
==========

Intraneural PN is rare benign slowly progressive nerve sheath tumour. Treatment management is still controversy discussed but seems to become more and more less invasive. At least, targeted biopsy should be performed to receive histopathological diagnosis. HRNS is increasingly used for follow-up examinations.

HRNS

:   High resolution nerve sonography

MRI

:   Magnetic resonance imaging

PN

:   Perineurioma
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